Advertisement

Topics

Phase 2 Discovery, Inc. Company Profile

16:03 EDT 23rd June 2018 | BioPortfolio

Phase 2 Discovery (P2D) is a pharmaceutical company focused on developing innovative drugs that fulfill unmet medical needs in the treatment of central nervous system (CNS) disorders such as insomnia, anxiety, depression, attention disorders and neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS).
At P2D, we are using our understanding of the treatment of CNS disorders and neurodegenerative diseases and our experienced team to efficiently build a product portfolio of therapeutics with a greater likelihood for clinical success. Our goal is to advance a product candidate through clinical proof of concept by producing powerful and compelling clinical data and then seeking partners to complete development and commercialization.

Location

3130 Highland Ave
Cincinnati
Ohio
45219
United States of America

Contact

Phone: (513) 475-6618
Fax: (513) 221-1891
Email: jmulchahey@phase2D.com


News Articles [1211 Associated News Articles listed on BioPortfolio]

ADC Therapeutics terminates phase I trial of ADCT─502 programme targeting HER2 expressing solid tumors

ADC Therapeutics (ADCT), an oncology drug discovery and development company, has terminated the phase I clinical trial to evaluate its antibody drug conjugate (ADC) ADCT─502 in patients with advance...

Chimerix Announces Discovery and Demonstrated Preclinical Activity Supporting Ongoing Phase 1 Study of New Antiviral for Treatment and Prevention of Norovirus

- CMX521 is Active In Vitro Against All Strains of Norovirus Tested - - Oral Dosing of CMX521 Inhibited Norovirus Replication in Animal Model - DURHAM, N.C., June 12, 2018 (GLOBE NEWSWIRE) -- C...

Innovation Pharma (IPIX) Posts Positive Phase 2 IBD Data

Recently, Innovation Pharma (OTCMKTS:IPIX) reported positive results for its phase 2 proof of concept clinical study. The results were presented at the Drug Discovery & Therapy World Congress in B...

Integrated lead discovery: An evolving toolbox

(SLAS (Society for Laboratory Automation and Screening)) A new SLAS Discovery review article by GlaxoSmithKline researchers in the US and UK offers an informative guide to the established and emerging...

PharmaMar Endures Second Recent Setback With Phase III Ovarian Cancer Failure

Zepsyre did not show a PFS advantage measured against a comparator regimen in platinum-resistant ovarian cancer, but the novel chemotherapy...   

Arena Ready For Etrasimod Phase III Face-Off With Celgene's Ozanimod In UC

With significant Phase II results in ulcerative colitis, Arena is planning a Phase III program for its selective S1P receptor...   

Artelo, Syngene Enter Partnership

For the drug discovery and clinical development of ART27.13, Artelo's Phase 2 ready, high-potency dual cannabinoid agonist

Hybrigenics (ALHYG) - Inecalcitol advancing towards data

Edison Investment Research - Pharmaceutical & healthcare - Hybrigenics: Hybrigenics’ main value driver is inecalcitol. A Phase II study in chronic myeloid leukaemia (CML) is on track to complete...

Drugs and Medications [21 Associated Drugs and Medications listed on BioPortfolio]

Caraderma [A Refreshing Discovery, Inc.]

CaraDerma acne treatment

Granisetron hydrochloride [Breckenridge Pharmaceutical, Inc.]

GRANISETRON HYDROCHLORIDE TABLETS, USP

Sprycel [E.R. Squibb & Sons, L.L.C.]

These highlights do not include all the information needed to use SPRYCEL safely and effectively. See full prescribing information for SPRYCEL. SPRYCEL (dasatinib) Tablet for Oral Use Initial U.S. App...

Temodar [Schering Corporation]

These highlights do not include all the information needed to use TEMODAR safely and effectively. See full prescribing information for TEMODAR. TEMODAR (temozolomide) CapsulesTEMODAR (temozolomide) fo...

Temodar [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use TEMODAR safely and effectively. See full prescribing information for TEMODAR. TEMODAR (temozolomide) CapsulesTEMODAR (temozolomide) fo...

PubMed Articles [1877 Associated PubMed Articles listed on BioPortfolio]

Improving the discovery of secondary metabolite natural products using ion mobility-mass spectrometry.

Secondary metabolite discovery requires an unbiased, comprehensive workflow to detect unknown unknowns for which little to no molecular knowledge exists. Untargeted mass spectrometry-based metabolomic...

Discovery of Rogaratinib (BAY 1163877): a pan-FGFR Inhibitor.

Rogaratinib (BAY 1163877) is a highly potent and selective small-molecule pan-fibroblast growth factor receptor (FGFR) inhibitor (FGFR1-4) for oral application currently being investigated in phase ...

Lorlatinib in ALK+ NSCLC: Robust Phase II Efficacy Seen.

The investigational ALK inhibitor lorlatinib, whose early clinical activity was first reported last year, continues to look promising in advanced ALK-positive or ROS1-positive non-small cell lung canc...

A Brain Phase Diagram of Neuronal Dynamics.

The extreme complexity of the brain has attracted the attention of neuroscientists and other researchers for a long time. More recently, the neuromorphic hardware has matured to provide a tool to stud...

Consideration of methods for identifying mite allergens.

House dust mites are small arthropods that produce proteins-found in their feces, body parts, and eggs-that are major triggers of human allergies worldwide. The goal of this review is to describe the ...

Clinical Trials [1367 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma

The purpose of the study is to better understand the function of asthma and COPD, and response to therapy. There are two Phases to this study broken into two arms. In Phase I, our propose ...

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Endometriosis Biomarker Discovery Study

This is a prospective, Single time point, discovery study intending to identify biomarkers that can differentiate endometriosis from other underlying reasons for pelvic pain. Patients unde...

Biologic Basis of Liver Cancer From Chronic Hepatitis B

The focus of the study is to identify viral factors and host immune responses that differentiate HBV-related HCC patients from HBV patients who have not progressed to HCC. To that end, the...

Companies [1863 Associated Companies listed on BioPortfolio]

ACADIA Pharmaceuticals Inc.

ACADIA is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders. ACA...

Newron Pharmaceuticals SpA

Newron Pharmaceuticals SpA is a clinical stage biopharmaceutical company focused on the discovery and development of small molecule drugs for the treatment of central nervous system (CNS) diseases. Ou...

DOV Pharmaceutical

We are a biopharmaceutical company focused on the discovery, acquisition, development and commercialization of novel drug candidates for central nervous system, cardiovascular and urological disorders...

Invicro LLC

Based in Boston, MA, Invicro was founded in 2008 with the mission of improving the role and function of imaging in translational drug discovery and development across all therapeu...

Euthymics Bioscience, Inc.

DOV is a biopharmaceutical company historically focused on the development of novel product candidates for disorders of the central nervous system. DOV has previously funded drug development and disco...

More Information about "Phase 2 Discovery, Inc." on BioPortfolio

We have published hundreds of Phase 2 Discovery, Inc. news stories on BioPortfolio along with dozens of Phase 2 Discovery, Inc. Clinical Trials and PubMed Articles about Phase 2 Discovery, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Phase 2 Discovery, Inc. Companies in our database. You can also find out about relevant Phase 2 Discovery, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Sleep Disorders
Sleep disorders disrupt sleep during the night, or cause sleepiness during the day, caused by physiological or psychological factors. The common ones include snoring and sleep apnea, insomnia, parasomnias, sleep paralysis, restless legs syndrome, circa...


Corporate Database Quicklinks



Searches Linking to this Company Record